Research Frontiers (Research Frontiers) Cash And Cash Equivalents

: $2.48 Mil (As of Dec. 2023)

View and export this data going back to 1986. Start your Free Trial

Research Frontiers's quarterly cash and cash equivalents declined from Jun. 2023 ($3.52 Mil) to Sep. 2023 ($0.53 Mil) but then increased from Sep. 2023 ($0.53 Mil) to Dec. 2023 ($2.48 Mil).

Research Frontiers's annual cash and cash equivalents increased from Dec. 2021 ($0.27 Mil) to Dec. 2022 ($4.23 Mil) but then declined from Dec. 2022 ($4.23 Mil) to Dec. 2023 ($2.48 Mil).

Research Frontiers Cash And Cash Equivalents Historical Data

The historical data trend for Research Frontiers's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Frontiers Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

6.59

4.77

0.27

4.23

2.48

Research Frontiers Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents																4.23	1.15	3.52	0.53	2.48

Research Frontiers Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Research Frontiers (NAS:REFR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Research Frontiers Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Research Frontiers's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Research Frontiers (Research Frontiers) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Research Frontiers Inc (NAS:REFR) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

240 Crossways Park Drive, Woodbury, NY, USA, 11797-2033

Website

https://www.smartglass.com

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.

Executives

Darryl Daigle	director	3213 WYTCHWOOD DRIVE, MORGAN CITY LA 70380
Eyal Peso	director	C/O GAUZY LTD., 14 HATHIYA STREET, TEL AVIV-YAFO L3 6816914
Kevin Douglas	10 percent owner, other: 13(d)(3) group	300A DRAKES LANDING ROAD, SUITE 200, GREENBRAE CA 94904
William Graham Settle	director	6003 COBRIDGE SQUARE, RALEIGH NC 27609
Michael R Lapointe	officer: Vice President-Marketing
Alexander Kaganowicz	director	1217 CARLLS STRAIGHT PATH, DIX HILLS NY 11746
Joseph M Harary	director, officer: Persident and CEO
Grimes George Gregory	director	24 FIFTH AVENUE, APT. 1530, NEW YORK NY 10011
Douglas Family Trust	10 percent owner, other: 13(d)(3) group	300A DRAKES LANDING ROAD, SUITE 200, GREENBRAE CA 94904
James & Jean Douglas Irrevocable Descendants Trust	10 percent owner, other: 13(d)(3) group	300A DRAKES LANDING ROAD, SUITE 200, GREENBRAE CA 94904
Voorhees Seth Van	officer: VicePresident-Business Dev/CFO	12 HARVEY DRIVE, SHORT HILLS NJ 07078
Robert L Saxe	director, officer: Chairman/CTO
Steven Michael Slovak	officer: Vice President-Technology	240 CROSSWAYS PARK DRIVE, WOODBURY NY 11797
Jack Derby	director	399 BOYLSTON STREET, BOSTON MA 02117
Victor F Keen	director	C/O RESEARCH FRONTIERS INC., 240 CROSSWAYS PARK DRIVE, WOODBURY NY 11797